Challenges of establishing new antithrombotic therapies in atrial fibrillation.
Connolly
Stuart J
SJ
Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. connostu@phri.ca
Eikelboom
John
J
O'Donnell
Martin
M
Pogue
Janice
J
Yusuf
Salim
S
D000818:Animals; D001281:Atrial Fibrillation / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D014859:Warfarin / Q000627:therapeutic use
D015507:Drugs, Investigational; D005343:Fibrinolytic Agents; D014859:Warfarin